Showing 221-230 of 2216 results for "".
Spontaneous Intracranial Hemorrhage Secondary to Rare Pial Arteriovenous Fistula Rupture
https://practicalneurology.com/diseases-diagnoses/stroke/spontaneous-intracranial-hemorrhage-secondary-to-rare-pial-arteriovenous-fistula-rupture/35445/Pial arteriovenous fistulas are rare cerebrovascular malformations most commonly seen in children; however, they can be found in adults, especially in the setting of an intracranial hemorrhage.Hometown Highlights: Procedural Treatments for Movement Disorders
https://practicalneurology.com/diseases-diagnoses/movement-disorders/hometown-highlights-procedural-treatments-formovement-disorders/31526/The Philadelphia Neurologic Society explores the journey from thalamotomy to MR-guided focused ultrasound for movement disorders.Mood Disorders Following Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/mood-disorders-following-traumatic-brain-injury/31994/Update on mood disorders, including depressive disorder and anxiety disorders along with accompanying symptoms, following TBIPrognostic Factors in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/prognostic-factors-in-multiple-sclerosis/31874/Prediction of highly active disease and rapid disability accumulation is crucial to optimizing clinical outcomes over time.Friedreich Ataxia: Pathophysiology and Treatment
https://practicalneurology.com/diseases-diagnoses/movement-disorders/friedreich-ataxia-pathophysiology-and-treatment/32041/Great strides have been made in understanding the pathophysiology of Friedreich ataxia, and a variety of treatments are available, including the first drug approved for Friedreich ataxia treatment in 2023.Poststroke Recrudescence:
Current Evidence and Considerations for Clinical Practicehttps://practicalneurology.com/diseases-diagnoses/stroke/poststroke-recrudescencebrcurrent-evidence-and-considerations-for-clinical-practice/32073/Despite the high prevalence of recrudescence after stroke and the importance of correct identification of recurrent cerebral ischemia, poststroke recrudescence is poorly understood.Challenge Case Report: Subacute Cognitive Decline
https://practicalneurology.com/diseases-diagnoses/imaging-testing/challenge-case-report-subacute-cognitive-decline/31579/Movement Disorders Moment: Deep Brain Stimulation in Movement Disorders: Recent Advances and Future Directions
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-deep-brain-stimulation-in-movement-disorders-recent-advances-and-future-directions/32061/The use of deep brain stimulation for movement disorders is advancing rapidly, allowing for increased customization and efficacy.Germline Sequence Variations in People with Central Nervous System Tumors
https://practicalneurology.com/diseases-diagnoses/neuro-oncology/Germline-Sequence-Variations-People-Central-Nervous-System-Tumors/33234/Germline sequence variations that predispose to cancer are common in people with central nervous system tumors, and neurologists should have a low threshold to refer people with these tumors to medical genetic specialists for counseling and consideration for testing.Multiple Sclerosis Minute: The Central Vein Sign in Diagnosis of Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-minute-the-central-vein-sign-in-diagnosis-of-multiple-sclerosis/31676/More accurate diagnosis is needed for multiple sclerosis and the central vein sign may be the needed imaging biomarker.